IL-SEVAN
23.6.2022 14:02:12 CEST | Business Wire | Press release
Sevan Multi-Site Solutions, Inc. (Sevan ) has earned the exclusive designation as a Certified Veteran’s Business Enterprise™ (VBE) from the National Veteran-Owned Business Association (NaVOBA).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220622005984/en/
Sevan, a global leader in innovative program management for clients with multiple sites, partnered with NaVOBA to receive the certification—which creates corporate contracting opportunities for veteran and service-disabled veteran businesses through certification, advocacy, outreach, recognition and education.
“Sevan is honored to be a Certified Veteran’s Business Enterprise™ via the National Veteran-Owned Business Association,” said Jim Evans, Founder and CEO of Sevan. “As a West Point graduate and former special forces officer, it’s a privilege to receive this designation. We greatly look forward to additional partnerships with other veteran owned organizations and clients across the restaurant, retail and government spaces.”
To be eligible for certification, organizations must be at least 51% owned, operated and controlled by one or more U.S. military veterans.
“Sevan becoming a Certified Veteran’s Business Enterprise™ is an incredibly exciting milestone for our team and organization,” said David Hendrix, Chief Commercial Officer. “Many of our clients are looking to maximize their diverse spend goals. Sevan now qualifies as a diverse supplier. We look forward to partnering with our current and new clients with this stamp of approval to contribute to our nation’s overall diverse spend initiatives.”
The certification process included a comprehensive list of business requirements and criteria, along with a rigorous examination and verification process. Certification enables Sevan to be more unique and competitive in the multi-site space.
“Corporations will not risk the accuracy of their Supplier Diversity spending goals by recording spend on contracts with firms that say they are owned by veterans if they aren’t absolutely certain of the ownership, operation and control of that firm,” said NaVOBA President Matthew Pavelek. “Working with a third-party nonprofit organization like NaVOBA and its VBE certification program provides that certainty.”
In 2022, Sevan was recognized as an Employee-Rated Great Place to Work® for the 9th consecutive year. In 2021, Sevan ranked on the Inc. 5000 list of the nation’s fastest-growing private companies for the 4th consecutive year. Also in 2021, Sevan ranked No. 21 on Engineering News-Record (ENR)’s Top 50 Program Management Firms, No. 44 on ENR’s Top 100 Construction Management-for-Fee Firms and earned the Gold HIRE Vets Medallion Award. In 2020, Sevan ranked No. 124 on the Financial Times FT 1000 list of America’s Fastest-Growing Companies. Visit our website to learn more about Sevan.
About Sevan
Sevan is an innovative global leader in design, program management, construction services and data analytics for organizations with multiple sites. Sevan puts capital to work—creating speed and scale—via dramatically enhanced efficiencies and accelerated schedules for high-quality program rollouts to maximize ROI. We partner with some of the world’s biggest brands and serve the unique needs of clients in the restaurant, retail and government spaces and create unlimited value. Sevan’s team spans across four countries and 40 states. As an extension of your team, our in-house experts manage capital improvement initiatives through every step of a program’s lifecycle.
Sevan helps iconic brands optimize their multi-site construction and facility programs in the United States and internationally. Sevan is headquartered near Chicago in Downers Grove, Illinois and has an international office in London.
Sevan has a passion for sustaining people, the environment and its clients’ businesses. Sevan strategically guides worldwide brands—including 7-Eleven, AAFES, Albertsons, Amtrak, BP, Carbon Health, Chipotle, Corvias, DaVita, Department of Veteran Affairs, Focus Brands, HCA Healthcare, HEB, Inspire Brands, Jiffy Lube, Kroger, Luxottica, McDonald’s, Motor Fuel Group, Office Depot, Popeyes, QDOBA, Starbucks, Sunoco, Walgreens Boots Alliance, Walmart, WOW Carwash and Yum! Brands—through their entire turnkey program lifecycle. Sevan rolls out multi-site initiatives efficiently, predictably and transparently. Applying breakthrough technology solutions, Sevan optimizes construction of new builds, rebuilds, remodels and renovations. Sevan has licensed architects in 49 states as well as D.C., Canadian provinces, Guam and the Northern Mariana Islands. Sevan has professional engineers on staff and general contractor licenses in more than 25 states. Since Sevan’s inception in 2011, the team has refreshed more than 25,000 retail stores, 17,000 restaurants and 32,000 healthcare sites. The team has also completed more than 32,000 surveys, totaling more than 1 billion square feet. Sevan Elevate, a program that reinforces and continuously improves safety and sustainability across the company, is designed to impactfully deliver excellence to Sevan’s people and clients.
To learn more about Sevan’s offerings, visit www.sevansolutions.com .
For more information, please contact Hafsa Mahmood by calling 708.723.3849 or via e-mail at hafsa.mahmood@sevansolutions.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220622005984/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
